Literature DB >> 2026481

Multipolar mitotic cells in the human cell line NHIK 3025 following treatment with the mitotic inhibitor NY 4137.

M E Juul1, J M Dornish, P E Schwarze, E O Pettersen, R Oftebro.   

Abstract

Treatment of human NHIK 3025 cells during interphase with the mitotic inhibitor 2-(2-thenyl) sulfonyl-5-bromopyrimidine (NY 4137) induced the formation of multipolar mitotic cells. A 4 h pulse treatment with 0.010 mM NY 4137 induced the formation of such cells regardless of whether treatment occurred in G1 or S phase. Approximately 35% of the cells originating from such multipolar mitotic divisions had less-than-normal G1 DNA content. Recordings of the DNA content of these small cells by means of flow cytometry showed that the amount of DNA per cell varied randomly. Subpopulations were separated by centrifugal elutriation on the basis of differences in cellular volume. Simultaneous two-parametric recordings of DNA versus total cellular protein showed that even though cells contained an amount of DNA less than G1 cells, there was a proportionality between DNA content and protein content despite variations in cell size.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026481     DOI: 10.1007/bf00194540

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  20 in total

1.  The Isolation and Biochemical Characterization of the Mitotic Apparatus of Dividing Cells.

Authors:  D Mazia; K Dan
Journal:  Proc Natl Acad Sci U S A       Date:  1952-09       Impact factor: 11.205

2.  Cell cycle characteristics of synchronized and asynchronous populations of human cells and effect of cooling of selected mitotic cells.

Authors:  E O Pettersen; O Bakke; T Lindmo; R Oftebro
Journal:  Cell Tissue Kinet       Date:  1977-11

3.  Effects of benzaldehyde on survival and cell-cycle kinetics of human cells cultivated in vitro.

Authors:  E O Pettersen; O Nome; O W Rønning; R Oftebro
Journal:  Eur J Cancer Clin Oncol       Date:  1983-04

4.  Progress through G1 and S in relation to net protein accumulation in human NHIK 3025 cells.

Authors:  O W Rønning; T Lindmo
Journal:  Exp Cell Res       Date:  1983-03       Impact factor: 3.905

5.  Binding of antimitotic drugs around cysteine residues of tubulin.

Authors:  H Schmitt; R Kram
Journal:  Exp Cell Res       Date:  1978-09       Impact factor: 3.905

6.  Effects of the new mitotic inhibitor pyrimidinsulfone NY 4137 on human cells in vitro and on colchicine binding to tubulin.

Authors:  M E Nygaard; J M Dornish; R Oftebro; K Undheim
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

7.  Inactivation of human cells cultivated in vitro by the new mitotic inhibitors NY 4137 and NY 4138.

Authors:  M E Nygaard; E O Pettersen; J M Dornish; K Undheim; R Oftebro
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

8.  DNA flow cytometry in primary breast carcinoma.

Authors:  S D Fosså; E Thorud; M C Shoaib; E O Pettersen; J Høie; O S Knudsen
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1984-11

9.  Sulfhydryl-related reduction of the mitotic inhibition and cell inactivation induced by pyrimidine analogs.

Authors:  M E Nygaard; J M Dornish; E O Pettersen; R Oftebro
Journal:  Anticancer Drug Des       Date:  1988-06

10.  The presence in mammalian liver and blood of substances which inhibit the mitotic activity of human cells grown in vitro.

Authors:  R OFTEBRO; P LALAND; J DEDICHEN; S LALAND; N THORSDALEN
Journal:  Br J Cancer       Date:  1963-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.